Synthetic cannabinoid use disorder: an update for general psychiatrists.

CONCLUSION:: When synthetic cannabinoid use is identified, along with management of acute physical and psychiatric adverse effects, psychotherapeutic strategies to reduce use and/or harm are recommended.
PMID: 30663326 [PubMed - as supplied by publisher]

Source: Australasian Psychiatry - January 21, 2019 Category: Psychiatry Authors: Grigg J, Manning V, Arunogiri S, Lubman DI Tags: Australas Psychiatry Source Type: research